Picture of Soleno Therapeutics logo

SLNO — Soleno Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Soleno Therapeutics Inc reports results for the quarter ended in January 1 - Earnings Summary

* Soleno Therapeutics Inc  SLNO.OQ  reported a quarterly
adjusted
loss of $1.83​​ per share for the quarter ended January 1, lower
than the same quarter last year, when the company reported EPS
of -95 cents.  The mean expectation of eight analysts for the
quarter was for a loss of 63 cents per share. Wall Street
expected results to range from -67 cents to -56 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Soleno Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.83​.
    * The company reported a quarterly loss of $76.62 million.
    * Soleno Therapeutics Inc shares had risen by 12.6% this
quarter and gained 41.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Soleno
Therapeutics Inc is $72.50 
This summary was machine generated from LSEG data November 7 at
05:20 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.63          -1.83          Missed
 Jun. 30 2024      -0.60          -0.57          Beat
 Mar. 31 2024      -0.37          -0.59          Missed
 Dec. 31 2023      -0.27          -0.33          Missed

Recent news on Soleno Therapeutics

See all news